Strategies to Mitigate Cisplatin-Induced Ototoxicity: A Literature Review of Protective Agents, Mechanisms, and Clinical Gaps
Background: Cisplatin, a widely used chemotherapeutic agent, is associated with significant ototoxicity, leading to progressive and irreversible sensorineural hearing loss in up to 93% of patients. Cisplatin generates reactive oxygen species (ROS) in the cochlea, activating apoptotic and necroptotic...
Saved in:
| Main Authors: | Alexandru Orasan, Mihaela-Cristina Negru, Anda Ioana Morgovan, Razvan Claudiu Fleser, Daniela Sandu, Adrian Mihail Sitaru, Alexandru-Catalin Motofelea, Nicolae Constantin Balica |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Audiology Research |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2039-4349/15/2/22 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ototoxicity and long-term hearing outcome in pediatric patients receiving cisplatin
by: Tatpong Sriyapai, et al.
Published: (2022-06-01) -
New application of ombuoside in protecting auditory cells from cisplatin-induced ototoxicity via the apoptosis pathway
by: Xingxing Wu, et al.
Published: (2024-10-01) -
Reversible p53 inhibition prevents cisplatin ototoxicity without blocking chemotherapeutic efficacy
by: Nesrine Benkafadar, et al.
Published: (2016-10-01) -
Sarsasapogenin protects hair cells from cisplatin-induced ototoxicity by attenuating apoptosis and ferroptosis via alleviating oxidative stress
by: Zhifeng Chen, et al.
Published: (2025-08-01) -
Ferulic Acid Combines with Ascorbic Acid to Target MMP9 to Attenuate Cisplatin-Induced Ototoxicity Through the p38MAPK Signaling Pathway
by: Guojun Yang, et al.
Published: (2025-05-01)